Fluoropyrimidine Activity (Homo sapiens)

From WikiPathways

Jump to: navigation, search


Contents



Curation Tags

Description

The main mechanism of 5-FU activation is conversion to fluorodeoxyuridine monophosphate (FdUMP) which inhibits the enzyme thymidylate synthase (TYMS), an important part of the folate-homocysteine cycle and purine and pyrimidine synthesis The conversion of 5-FU to FdUMP can occur via thymidylate phosphorylase (TYMP) to fluorodeoxyuridine (FUDR) and then by the action of thymidine kinase to FdUMP or indirectly via fluorouridine monophosphate (FUMP) or fluroridine (FUR) to fluorouridine diphosphate (FUDP) and then ribonucleotide reductase action to FdUDP and FdUMP. FUDP and FdUDP can also be converted to FUTP and FdUTP and incorporated into RNA and DNA respectively which also contributes to the pharmacodynamic actions of fluoropyrimidines. Sources: PharmGKB:Fluoropyrimidine Pharmacokinetics, PharmGKB:Fluoropyrimidine Pharmacodynamics, Wikipedia:Fluorouracil

Ontology Tags

 

Bibliography

View all 36 references
  1. Yuan JH, Cheng JQ, Jiang LY, Ji WD, Guo LF, Liu JJ, Xu XY, He JS, Wang XM, Zhuang ZX; ''Breast cancer resistance protein expression and 5-fluorouracil resistance.; ''Biomed Environ Sci, 2008 - PubMed
  2. De Angelis PM, Svendsrud DH, Kravik KL, Stokke T; ''Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.; ''Mol Cancer, 2006 - PubMed
  3. Wu X, Gu J, Wu TT, Swisher SG, Liao Z, Correa AM, Liu J, Etzel CJ, Amos CI, Huang M, Chiang SS, Milas L, Hittelman WN, Ajani JA; ''Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer.; ''J Clin Oncol, 2006 - PubMed
  4. Gusella M, Padrini R; ''G>C SNP of thymidylate synthase with respect to colorectal cancer.; ''Pharmacogenomics, 2007 - PubMed
  5. De Mattia E, Toffoli G; ''C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisation.; ''Eur J Cancer, 2009 - PubMed
  6. Behera RK, Nayak R; ''Expression profiling of nucleotide metabolism-related genes in human breast cancer cells after treatment with 5-fluorouracil.; ''Cancer Invest, 2009 - PubMed
  7. van Kuilenburg AB, Meinsma R, Zonnenberg BA, Zoetekouw L, Baas F, Matsuda K, Tamaki N, van Gennip AH; ''Dihydropyrimidinase deficiency and severe 5-fluorouracil toxicity.; ''Clin Cancer Res, 2003 - PubMed
  8. Nordgard SH, Alnaes GI, Hihn B, Lingjaerde OC, Liestøl K, Tsalenko A, Sørlie T, Lønning PE, Børresen-Dale AL, Kristensen VN; ''Pathway based analysis of SNPs with relevance to 5-FU therapy: relation to intratumoral mRNA expression and survival.; ''Int J Cancer, 2008 - PubMed
  9. Kunz C, Focke F, Saito Y, Schuermann D, Lettieri T, Selfridge J, Schär P; ''Base excision by thymine DNA glycosylase mediates DNA-directed cytotoxicity of 5-fluorouracil.; ''PLoS Biol, 2009 - PubMed
  10. Hagmann W, Jesnowski R, Faissner R, Guo C, Löhr JM; ''ATP-binding cassette C transporters in human pancreatic carcinoma cell lines. Upregulation in 5-fluorouracil-resistant cells.; ''Pancreatology, 2009 - PubMed
  11. Jensen SA, Vainer B, Witton CJ, Jørgensen JT, Sørensen JB; ''Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer.; ''Acta Oncol, 2008 - PubMed
  12. Kidd EA, Yu J, Li X, Shannon WD, Watson MA, McLeod HL; ''Variance in the expression of 5-Fluorouracil pathway genes in colorectal cancer.; ''Clin Cancer Res, 2005 - PubMed
  13. Kobayashi Y, Ohshiro N, Sakai R, Ohbayashi M, Kohyama N, Yamamoto T; ''Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7]).; ''J Pharm Pharmacol, 2005 - PubMed
  14. Peters EJ, Kraja AT, Lin SJ, Yen-Revollo JL, Marsh S, Province MA, McLeod HL; ''Association of thymidylate synthase variants with 5-fluorouracil cytotoxicity.; ''Pharmacogenet Genomics, 2009 - PubMed
  15. Karasawa H, Miura K, Fujibuchi W, Ishida K, Kaneko N, Kinouchi M, Okabe M, Ando T, Murata Y, Sasaki H, Takami K, Yamamura A, Shibata C, Sasaki I; ''Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells.; ''Cancer Sci, 2009 - PubMed
  16. Diasio RB, Harris BE; ''Clinical pharmacology of 5-fluorouracil.; ''Clin Pharmacokinet, 1989 - PubMed
  17. Ruzzo A, Graziano F, Loupakis F, Santini D, Catalano V, Bisonni R, Ficarelli R, Fontana A, Andreoni F, Falcone A, Canestrari E, Tonini G, Mari D, Lippe P, Pizzagalli F, Schiavon G, Alessandroni P, Giustini L, Maltese P, Testa E, Menichetti ET, Magnani M; ''Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy.; ''Pharmacogenomics J, 2008 - PubMed
  18. Farrell JJ, Elsaleh H, Garcia M, Lai R, Ammar A, Regine WF, Abrams R, Benson AB, Macdonald J, Cass CE, Dicker AP, Mackey JR; ''Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.; ''Gastroenterology, 2009 - PubMed
  19. Marsh S; ''Thymidylate synthase pharmacogenetics.; ''Invest New Drugs, 2005 - PubMed
  20. Boyer J, Allen WL, McLean EG, Wilson PM, McCulla A, Moore S, Longley DB, Caldas C, Johnston PG; ''Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer.; ''Cancer Res, 2006 - PubMed
  21. Longley DB, Harkin DP, Johnston PG; ''Incorporation of 3H-dibromodulcitol and 3H-dianhydrodulcitol into ascites tumor cells. Autoradiographic study.; ''Neoplasma, 1976 - PubMed
  22. Tsujie M, Nakamori S, Nakahira S, Takahashi Y, Hayashi N, Okami J, Nagano H, Dono K, Umeshita K, Sakon M, Monden M; ''Human equilibrative nucleoside transporter 1, as a predictor of 5-fluorouracil resistance in human pancreatic cancer.; ''Anticancer Res, 2007 - PubMed
  23. Sobrero AF, Aschele C, Bertino JR; ''Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation.; ''J Clin Oncol, 1997 - PubMed
  24. Gmeiner WH; ''Novel chemical strategies for thymidylate synthase inhibition.; ''Curr Med Chem, 2005 - PubMed
  25. Humeniuk R, Menon LG, Mishra PJ, Gorlick R, Sowers R, Rode W, Pizzorno G, Cheng YC, Kemeny N, Bertino JR, Banerjee D; ''Decreased levels of UMP kinase as a mechanism of fluoropyrimidine resistance.; ''Mol Cancer Ther, 2009 - PubMed
  26. Miwa M, Ura M, Nishida M, Sawada N, Ishikawa T, Mori K, Shimma N, Umeda I, Ishitsuka H; ''Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.; ''Eur J Cancer, 1998 - PubMed
  27. An Q, Robins P, Lindahl T, Barnes DE; ''5-Fluorouracil incorporated into DNA is excised by the Smug1 DNA glycosylase to reduce drug cytotoxicity.; ''Cancer Res, 2007 - PubMed
  28. Huang MY, Fang WY, Lee SC, Cheng TL, Wang JY, Lin SR; ''ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: a preliminary study.; ''BMC Cancer, 2008 - PubMed
  29. Sakamoto E, Tsukioka S, Oie S, Kobunai T, Tsujimoto H, Sakamoto K, Okayama Y, Sugimoto Y, Oka T, Fukushima M; ''Folylpolyglutamate synthase and gamma-glutamyl hydrolase regulate leucovorin-enhanced 5-fluorouracil anticancer activity.; ''Biochem Biophys Res Commun, 2008 - PubMed
  30. Yen-Revollo JL, Goldberg RM, McLeod HL; ''Can inhibiting dihydropyrimidine dehydrogenase limit hand-foot syndrome caused by fluoropyrimidines?; ''Clin Cancer Res, 2008 - PubMed
  31. Yuan J, Lv H, Peng B, Wang C, Yu Y, He Z; ''Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer.; ''Cancer Chemother Pharmacol, 2009 - PubMed
  32. Iacopetta B, Kawakami K, Watanabe T; ''Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracil-responsive subgroup?; ''Int J Clin Oncol, 2008 - PubMed
  33. Wang W, Cassidy J, O'Brien V, Ryan KM, Collie-Duguid E; ''Mechanistic and predictive profiling of 5-Fluorouracil resistance in human cancer cells.; ''Cancer Res, 2004 - PubMed
  34. Cao D, Russell RL, Zhang D, Leffert JJ, Pizzorno G; ''Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines.; ''Cancer Res, 2002 - PubMed
  35. Thomas HR, Ezzeldin HH, Guarcello V, Mattison LK, Fridley BL, Diasio RB; ''Genetic regulation of dihydropyrimidinase and its possible implication in altered uracil catabolism.; ''Pharmacogenet Genomics, 2007 - PubMed
  36. Huang ZH, Hua D, Li LH, Zhu JD; ''Prognostic role of p53 codon 72 polymorphism in gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy.; ''J Cancer Res Clin Oncol, 2008 - PubMed

Categories


History

View all
CompareRevisionActionTimeUserComment
59843view19:15, 8 March 2013KhanspersUpdated reference for dUMP
54388view21:16, 28 November 2012EgonwAdded the PubChem Compound ID for FUMP.
54353view11:50, 28 November 2012EveloSpecify description
54352view11:09, 28 November 2012EveloAdded Capecitabine ID from Chebi
54351view10:49, 28 November 2012EveloAdded (Chebi) IDs for 5FU itself
54350view10:35, 28 November 2012AnweshaPeriodical save, work in progress
47632view19:47, 31 March 2012AlexanderPicoadded db refs
46342view23:46, 18 January 2012KhanspersChanged cell shapes back to rounded rectangle
46341view22:39, 18 January 2012KhanspersRepalced rounded rectangles with rectangles
46305view17:39, 13 January 2012KhanspersAdded WikiPathways identifiers to pathway nodes
42640view21:09, 11 April 2011Khanspersfixed lines
41174view23:42, 1 March 2011MaintBotRemoved redundant pathway information and comments
39389view22:25, 19 November 2010AlexanderPicoOntology Term : 'hepatocyte' added !
39388view22:23, 19 November 2010AlexanderPicoOntology Term : 'drug pathway' added !
39387view22:23, 19 November 2010AlexanderPicoOntology Term : 'cancer' added !
39386view22:22, 19 November 2010AlexanderPicoupdated cells
38478view18:18, 17 September 2010AlexanderPicoModified description
38303view21:48, 30 August 2010AlexanderPicoReverted to version '14:42, 30 August 2010' by AlexanderPico
38302view21:47, 30 August 2010AlexanderPico
38301view21:42, 30 August 2010AlexanderPico
38291view07:56, 30 August 2010AlexanderPicoModified categories
38290view07:54, 30 August 2010AlexanderPico
38289view07:47, 30 August 2010AlexanderPicoadding literature refs
38288view07:22, 30 August 2010AlexanderPicoModified description
38286view07:18, 30 August 2010AlexanderPicocompleted
38285view07:02, 30 August 2010AlexanderPicoPeriodical save, work in progress
38283view06:52, 30 August 2010AlexanderPicoPeriodical save, work in progress
38282view01:05, 30 August 2010AlexanderPicostarter
38281view00:56, 30 August 2010AlexanderPicoPeriodical save, work in progress
38280view00:45, 30 August 2010AlexanderPicoPeriodical save, work in progress
38279view00:35, 30 August 2010AlexanderPicoPeriodical save, work in progress
38278view00:25, 30 August 2010AlexanderPicoNew pathway

External references

View all 59...

Name Type Database reference
UCK1GeneProduct83549 (Entrez Gene)
ABCG2GeneProduct9429 (Entrez Gene)
Folate CyclePathway
ABCC4GeneProduct10257 (Entrez Gene)
ABCC3GeneProduct8714 (Entrez Gene)
5-fluorouracil (5-FU)Metabolite46345 (ChEBI)
DHFRGeneProduct1719 (Entrez Gene)
5-FUMetabolite46345 (ChEBI)
TK1GeneProduct7083 (Entrez Gene)
TegafurMetabolite5193 (Chemspider)
5,10-MethenyltetrahydrofolateMetaboliteHMDB01354 (HMDB)
CYP2A6GeneProduct1548 (Entrez Gene)
ERCC2GeneProduct2068 (Entrez Gene)
5-hydroxytegafurMetabolite
SLC22A7GeneProduct10864 (Entrez Gene)
CapecitabineMetabolite31348 (ChEBI)
UMPSGeneProduct7372 (Entrez Gene)
5-dFCRMetabolite
RRM2GeneProduct6241 (Entrez Gene)
5-dFURMetabolite
SLC29A1GeneProduct2030 (Entrez Gene)
CES1GeneProduct1066 (Entrez Gene)
dUMPMetaboliteHMDB01409 (HMDB)
CES2GeneProduct8824 (Entrez Gene)
DNA RepairPathwayWP1805 (WikiPathways)
CDAGeneProduct978 (Entrez Gene)
XRCC3GeneProduct7517 (Entrez Gene)
UPP1GeneProduct7378 (Entrez Gene)
MTHFRGeneProduct4524 (Entrez Gene)
UPP2GeneProduct151531 (Entrez Gene)
UPB1GeneProduct51733 (Entrez Gene)
TYMPGeneProduct1890 (Entrez Gene)
UCK2GeneProduct7371 (Entrez Gene)
DHFUMetabolite
PPATGeneProduct5471 (Entrez Gene)
FUPAMetabolite
RRM1GeneProduct6240 (Entrez Gene)
FBALMetabolite
TYMSGeneProduct7298 (Entrez Gene)
FURMetabolite
ABCC5GeneProduct10057 (Entrez Gene)
FUMPMetabolite150856 (PubChem-Compound)
LeucovorinMetabolite
FUDPMetabolite
DihydrofolateMetaboliteHMDB01056 (HMDB)
FUTPMetabolite
dTMPMetaboliteHMDB01056 (HMDB)
FUDRMetabolite
ApoptosisPathwayWP254 (WikiPathways)
FdUMPMetabolite
TP53GeneProduct7157 (Entrez Gene)
FdUDPMetabolite
TDGGeneProduct6996 (Entrez Gene)
FdUTPMetabolite
SMUG1GeneProduct23583 (Entrez Gene)
DPYDGeneProduct1806 (Entrez Gene)
FPGSGeneProduct2356 (Entrez Gene)
DPYSGeneProduct1807 (Entrez Gene)
GGHGeneProduct8836 (Entrez Gene)
Retrieved from "http://wikipathways.org/index.php/Pathway:WP1601"
Personal tools
Navigation